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Abstract
Objective To introduce a new online generic decision support sys-
tem based on multicriteria decision analysis (MCDA), imple-
mented in practical and user-friendly software (Annalisa©).
Background All parties in health care lack a simple and generic
way to picture and process the decisions to be made in pursuit of
improved decision making and more informed choice within an
overall philosophy of person- and patient-centred care.
Methods The MCDA-based system generates patient-speciﬁc clini-
cal guidance in the form of an opinion as to the merits of the alter-
native options in a decision, which are all scored and ranked. The
scores for each option combine, in a simple expected value calcula-
tion, the best estimates available now for the performance of those
options on patient-determined criteria, with the individual
patient’s preferences, expressed as importance weightings for those
criteria. The survey software within which the Annalisa ﬁle is
embedded (Elicia©) customizes and personalizes the presentation
and inputs. Principles relevant to the development of such deci-
sion-speciﬁc MCDA-based aids are noted and comparisons with
alternative implementations presented. The necessity to trade-oﬀ
practicality (including resource constraints) with normative rigour
and empirical complexity, in both their development and delivery,
is emphasized.
Conclusion The MCDA-/Annalisa-based decision support system
represents a prescriptive addition to the portfolio of decision-aid-
ing tools available online to individuals and clinicians interested in
pursuing shared decision making and informed choice within a
commitment to transparency in relation to both the evidence and
preference bases of decisions. Some empirical data establishing its
usability are provided.
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Introduction: multicriteria decision making
Asked how they make a decision, health pro-
fessionals, either individually or as part of a
multidisciplinary medical team, will often say
something like
Together with the patient we look at the avail-
able options to see how well each performs on
the main eﬀect beneﬁt, then take into account
the side eﬀect and adverse event harms, the bur-
dens of the treatment and so on, ﬁnally weighing
the beneﬁts and harms and any other consider-
ations to arrive at a conclusion as to the best
option. We naturally bear in mind what the most
recent relevant high quality guidelines have to
say.
A patient responding to the same question
will probably come up with something similar,
albeit expressed in diﬀerent words such as ‘tak-
ing the ‘pros and cons’ into account’ and ‘giv-
ing all the considerations due weight’.
Clearly, these are not accurate characteriza-
tions of all clinical decision-making processes,
but would seem to be reasonably descriptive of
many. More importantly, they would certainly
be common responses when the prescriptive
question is asked: ‘How should a clinical deci-
sion be made?’
These sorts of statements indicate that we
operate in a health-care system where some
form of shared decision making is accepted as
the aim. The majority of health professionals
routinely ‘talk the talk’ of informed choice and
patient-centred care, increasingly emphasizing
‘patient-important outcomes’ as promoted by
the Grading of Recommendations Assessment,
Development, and Evaluation (GRADE) col-
laboration1 and the newly established Patient-
Centered Outcomes Research Institute (PCO-
RI) (http://www.pcori.org) among many other
individuals and groups. They do so with genu-
ine conviction and intent, but ﬁnd it more diﬃ-
cult to ‘walk the walk’2,3 and even to agree on
what the key steps should be in terms of pace,
direction and support.
The presence of cultural and socio-economic
variations, together with great individual heter-
ogeneity within cultures and classes, is at the
heart of the challenge posed in pursuing shared
decision making (and informed choice) within
an overall philosophy of person- and patient-
centred care. The challenge to the professionals
is mirrored by that of the individuals with
whom they engage. All parties lack a simple
and generic way to picture and communicate
about the decisions that need to be made in
health care. We seek to address this major
handicap to progress towards all three goals.
For convenience, the discussion is focused on
the encounter between individual clinician and
patient, but we regard our proposal as apply-
ing beyond the microclinical setting, to the
meso- and macrolevels of health-care decision
and policymaking.
Two broad types of decision technology are
compatible with shared decision making. The
ﬁrst is that captured in the opening quotes. As
it takes some form of argumentation conducted
in words, even if it refers to numbers as inputs,
we feel an appropriate shorthand term for it is
verbal multicriteria decision deliberation
(MCDD). It embraces all forms of decision
making that occur through deliberative pro-
cesses, including those which are based on deci-
sion aids and support grounded in descriptive
theories of human decision behaviour, usually
involving descriptive theories of expert decision
making.4 It dominates recent work in relation
to shared decision making and patient-centred
decision support.5–7 MCDD is a useful term
because it highlights the key similarities and
diﬀerences with the alternative decision (and
decision support) technology that we argue
should be included in the portfolio of clinical
decision-making competencies of both health
professionals and patients. This alternative is
based on the well-established, theoretically
grounded, prescriptive technique of multicrite-
ria decision analysis (MCDA).8 To make the
comparison with verbal MCDD even clearer,
we can imagine the adjective numerical preced-
ing it.
In short, we are suggesting, along with
Dolan,9 van Hummel and Ijzerman10 and Liber-
atore and Nydick11 that numerical MCDA
(hereafter simply MCDA) be added to the
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competency portfolio of all those involved in
clinical decision making. We regard their studies
as establishing that MCDA -based clinical deci-
sion support systems can be successfully devel-
oped and deployed. However, despite the high
quality of the eﬀorts of these researchers, the
implementation of MCDA-based decision sup-
port in health care has been fairly limited – not
that the success of MCDD-based aids in routine
practice has been spectacular to date.12,13 The
reasons for this undoubtedly include the usabil-
ity and communicability of the current software
implementations of MCDA technique, comput-
erization being a necessary condition for its
application, in contrast to MCDD. In this
respect, we believe it reasonable to infer that an
implementation which is superior in these
respects will be more successful and can be
regarded a priori as a workable clinical decision
support system. But the reasons also trace back
to the fundamentally diﬀerent theoretical para-
digm from which MCDA itself emanates, com-
pared with that underlying current clinical
practice and the majority of decision aids built
for use within it (a comprehensive inventory of
patient decision aids is available at http://deci-
sionaid.ohri.ca/index.html). It is vital to keep
this in mind in any attempted evaluation.
MCDD and MCDA: similarities and
differences
There are two key similarities between the
two broad modes of multicriteria decision
making, the umbrella term. First, both imply
that in every clinical decision, two sorts
of judgement are needed: (i) on the perfor-
mance of each of the available options on
each of the multiple relevant considerations
and (ii) on the relative importance of those
multiple considerations. Second, that these
conceptually diﬀerent types of input must be
integrated/synthesized/combined in some way
to arrive at a decision.
The key diﬀerences are reﬂected in the ﬁnal
words of the labels – deliberation and analysis
– and in the preceding, implied adjectives –
verbal and numerical. (In this paper, we
include a graphical representation of data
within the scope of the latter term.)
It might be asked why we characterize the
distinction as a ‘verbal/numerical’ contrast,
rather than a ‘qualitative/quantitative’ one. We
do so because it is crucial to accept that
MCDD is replete with the quantiﬁcation of
magnitudes. This quantiﬁcation is simply done
in predominantly verbal ways during the deci-
sion-making parts of the discourse. This
applies in relation to the performance magni-
tude judgements, for example, of diﬀerent med-
ications reducing the chance of Pain, where
terms such as ‘low probability’, ‘good chance’
and ‘very likely’ are used to characterize the
chances of the criterion being met for this
patient. It also applies to the relative impor-
tance judgements, for example, of the impor-
tance of pain reduction relative to medication
side eﬀects, where again a variety of terms such
as ‘paramount’, ‘trivial’ and ‘major’ – or sim-
ply ‘very important’ and ‘not very important’ –
are deployed.
The word Analysis is used because the expli-
cit aim in MCDA (and in fact of any version
of decision analysis, including its cost-eﬀective-
ness and cost-utility forms) is to arrive at a
result – an opinion is our preferred term – by a
process of analytical calculation on the basis of
numerical judgments. Of course, the process of
arriving at those numerical judgements almost
certainly involves extensive verbal, non-numeri-
cal elements and hence deliberation, in the
same way that the deliberative discourse of
MCDD may contain many judgments of mag-
nitudes, including some expressed numerically.
Deliberation on the other hand is an interper-
sonal process where the provenance of the
emerging conclusion inheres in the social pro-
cess adopted and the participants involved in
it. Unless the deliberation is structured as an
MCDA,14 the conclusion cannot be detached
from them in the form of a graphic summary,
or equation, or set of numerical option scores.
A process that would beneﬁt from the per-
ceived strengths of each approach is an attrac-
tive prospect, and such a hybrid form has been
implemented by Proctor and Drechsler in the
© 2013 The Authors. Health Expectations published by John Wiley & Sons Ltd.
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context of environmental policy formation.14 A
‘stakeholder jury’ was used to structure an
MCDA through a deliberative process and
populate it with the help of experts. MCDD
then followed as the ﬁnal stage. The extensive
time and resources involved, as well as the
environmental policy context, make the empiri-
cal conclusions of limited relevance, but the
hybrid case is well made in general. However,
such a hybrid involves compromise from both
sides, and this is not easy once it becomes clear
that paradigmatic principles are involved, not
merely syntactic or semantic diﬀerences that
can be addressed by ‘translation’, for example,
of verbal magnitude quantiﬁers into numerical
ones. These paradigmatic diﬀerences need to be
articulated before proceeding.
The objective of decision support is to
improve decisions. This means establishing
whether improvements can be made, identify-
ing where improvements could be made and
providing support that will lead to improve-
ments. The concept of improvement means one
cannot avoid being prescriptive. Purely descrip-
tive approaches, which focus on describing
how decisions are made – by individuals or by
organizations, communities and other groups –
provide no basis for change as they have no
basis for identifying what would be an
improvement.15 Purely normative approaches,
which focus on establishing, without reference
to how decisions are made, the fundamental
principles and processes that an ideal deci-
sion maker would implement, are simply
impractical.
On what basis can such desirable, potentially
decision-improving prescriptions for decision-
making processes be identiﬁed? There are two
main possible bases.
One basis is the normative principles of deci-
sion theory and decision analysis. Decision
analysis is essentially the ideal processes of
decision theory converted into processes that
are practical, given the time, resource and cog-
nitive constraints of the real world. Lipshitz
and Cohen4 call prescription arrived at on this
basis analysis-based prescription, and this is
exactly what we mean when we say MCDA-
based decision aids are ’prescriptive’. They pro-
duce an opinion which reﬂects, as closely as
practicable – for many reasons this may not
be very close at all – the logical processes of an
idealized decision maker. Interestingly these
principles and processes have been endorsed by
many people if they are asked how a decision
should be made, even when they do not follow
the principles and processes themselves.4
The other possible basis of prescriptions for
improvement in decision making is descrip-
tion of the decision processes of expert decision
makers, on the one hand, in contrast to non-
expert decision makers on the other. The for-
mer are deﬁned as those whose decisions gener-
ally produce good results and outcomes.
Identifying the diﬀerences between them –
what makes the experts expert – can lead to
what Lipshitz and Cohen call expertise-
based prescription. Despite the accuracy of this
term, in the world of decision support the term
‘prescriptive’ is almost exclusively associated
with the analysis-based approach. Those who
favour the expertise-based approach prefer to
characterize themselves as operating within an
descriptive approach, which in many ways is
true, even though, by deﬁnition, prescription is
necessary to distinguish experts from non-
experts and good from not-good results.16
Expertise-based description/prescription has
been virtually the only route to improvement
in decisions considered professionally accept-
able in clinical medicine, and this is reﬂected in
the curricula of medical schools and in clinical
practice. Decision analysis is rare to non-exis-
tent in both the curricula of medical schools
and in clinical practice. It is also the basis for
the regular attacks on the ‘expected utility/
value’ principle which underlies analysis-based
prescription. These critiques, most recently that
of Russell and Schwartz,17 are always derived
from the descriptive inadequacies of the
expected value principle. But such inadequacies
are ultimately irrelevant within a prescriptive
paradigm because it is not derived from actual
behaviour. As it is hard to conceive of unbi-
ased cross-paradigm evaluation, it is not sur-
prising that this is never proposed in such
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critiques, which ultimately reﬂect the intuitive
appeal of descriptive approaches that seek to
‘take into account’ the complex characteristics,
history and contexts of the individual. The
issue is not whether these inadequacies and
complexities exist – are descriptively true – but
whether a user would prefer to be supported
by analysis-based prescription or expertise-
based description. The ethical responsibility is
to make clear the paradigmatic origins of the
type of support oﬀered.
The analysis-based prescriptive approach has
one compelling advantage in the provision of
patient/person-centred care and genuinely
shared decision making. In its multicriteria
form, decision analysis provides a generic
approach to all decisions, that is, it is not con-
dition speciﬁc and does not mandate the rea-
soning expertise and knowledge acquisition in
the particular area (e.g. a disease) required to
follow and share expertise-based prescriptions.
As long as expertise-based prescription is the
sole basis of the clinical encounter, patient
empowerment will be a very diﬃcult and
demanding task. An MCDA-based prescriptive
approach allows the person/patient to input
their preferences as importance weights for cri-
teria in a straightforward manner and to have
them transparently combined with the pub-
lished evidence and the clinician’s expertise.
Developing an MCDA-based decision
support system
This paper focuses on MCDA as an appropri-
ate technique for facilitating person-centred
health care in relation to the adoption decision
– deciding what to do given the available
options. It is important to distinguish this deci-
sion from two other decisions where we also
regard MCDA as an appropriate support tech-
nique. One is the quality decision – deciding
how good the decision just taken was, given
the decision technology used. An MCDA-
based instrument for measuring decision qual-
ity has been developed and is presented in J.
Dowie, M. Kjer Kaltoft, G. Salkeld and M.
Cunich (submitted). The other is the decision
decision – deciding how to decide, given the
available decision technologies. In our case, the
decision decision is whether the adoption deci-
sion is to be made by the exercise of the health
professional’s ‘clinical judgment’, by some form
of MCDD-based decision making, or in con-
junction with some type of MCDA-based deci-
sion support? We return to this central, ‘meta’
question later.
A great number of software implementations
of MCDA exist, reﬂecting both widely varying
versions of the technique and particular judge-
ments about the extent and type of complexity
to be catered for and the time and cognitive
resources required.18,19 These range from
implementations of a SMART (Simple Multi
Attribute Rating System) in a simple spread-
sheet, implementations using the analytic
hierarchy process (AHP) as executed either in
a spreadsheet template or a dedicated soft-
ware package, notably Expert Choice, http://
expertchoice.com/products-services/expert-choice-
desktop/, to speciﬁc MCDA implementations
such as V.I.S.A http://www.visadecisions.com,
HiView http://www.catalyze.co.uk/index.php/soft
ware/hiview3/, Web-Hipre http://hipre.aalto.ﬁ/
and Logical Decisions http://www.logicaldeci
sions.com/. The latter two packages also con-
tain an AHP option. The prime motivation for
developing an MCDA decision support system
in the form of Annalisa was that none of the
existing implementations of MCDA had,
despite proving themselves as clinical decision
support systems, made signiﬁcant progress in
health care. That was the situation when An-
nalisa was ﬁrst conceived and we feel it
remains true now, despite the growing research
in this area (see Dolan,9 Maarten Ijzerman and
colleagues,20 and other examples cited in the
Liberatore review).11 Most of the increasing
use of MCDA in health care is at the policy
and health technology assessment level, with
the recent developments within the EVIDEM
framework and software in the forefront21,22
conﬁned to this setting.
In deliberately implementing the simplest,
compensatory ‘weighted-sum’ version of the
MCDA technique we make no claim of it
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being innovatory as a decision model. It is, in
essential respects, an enhanced interface for
any SMART-type matrix. These can easily be
developed in a spreadsheet. However, Annalisa
seeks to provide enhanced interactive online
usability by way of the numerous customizing
and personalizing functionalities provided in
the survey program Elicia, into which the An-
nalisa ﬁle is normally embedded. For example,
Annalisa enables personalization of the perfor-
mance ratings of options on criteria on the
basis of patient characteristics and personaliza-
tion of the weightings of the criteria by the
patient at the point of decision.
Thus, the focus of this paper is not to re-intro-
duce MCDA or conﬁrm its value as the basis for
clinical decision support systems, but to intro-
duce a particular software template, Annalisa,
as a practical and person-centred implementa-
tion for use at the individual level, not only in
shared decision making, but also in the commu-
nity, especially in relation to cancer and other
disease screening decisions and policies.
The AHP has been the MCDA implementa-
tion used most widely in the clinical health-care
context and warrants special mention. In an
extensive series of papers, James Dolan has
expounded and investigated the ways it can
contribute to both shared decision making and
the wider issues involved in clinical decision
support.8,9,23 However, in its standard form,
AHP involves a level of complexity that
imposes high demands on both the developers
and implementers/users of AHP-based support
systems. Primarily responsible for this
increased complexity is the hierarchical attri-
bute structure which AHP permits and indeed
encourages (hence its name) and the unique
pairwise comparison method used to establish
criteria importance weights and perfor-
mance ratings, devised by its founder, Thomas
Saaty.24 While this increased complexity can be
seen as leading to a high level of performance
by some standards of normative rigour and
comprehensiveness,25 it creates the diﬃculties
in the development and delivery of AHP-based
decision support26 that have hindered its wider
dissemination.
French and Rios Insua27 propose 5 key char-
acteristics that any ‘good’ implementation of
decision analysis, single or multi criteria,
should possess. We use them, as summarized
by Riabacke et al.,28 to highlight the basis of
the claims of Annalisa in each respect.
1. Axiomatic basis. The axiomatic bases under-
lying Annalisa are those of decision theory.
All the implementations of MCDA men-
tioned in this paper embody some version of
the weighted-sum principle which is at the
centre of decision theory. Annalisa imple-
ments this basic principle in a very simple
way while still retaining its key principles.
2. Feasibility. Feasibility has been the main
driving force in the development of Anna-
lisa. The template was explicitly designed to
reduce the complexity – and resulting cogni-
tive demands – that is possible and tends to
be facilitated by increasingly sophisticated
implementations within the other available
packages.
3. Robustness. No provision for sensitivity
analysis is built into Annalisa, but both the
weightings and ratings can be directly varied
and the eﬀect on scores instantly observed.
4. Transparency to users. In best practice
implementation, the weighted-sum principle
is not only explained and illustrated prior to
the user’s interaction with Annalisa, but
also during interaction where appropriate,
for example when and whether the individ-
ual panels (Weightings, Ratings, Scores) are
opened or closed at diﬀerent stages during
engagement. Application of the weighted-
sum principle is manifestly transparent on
any populated Annalisa screen.
5. Compatibility with a wider philosophy. This
criterion relates to the model developed in
the software rather than to its basic func-
tionalities. It is up to the user of Annalisa
to develop a model relevant to their context
and setting. The embedding of Annalisa in
the online survey program Elicia makes in-
teractivity and cyclical iteration simple and
eﬃcient and leaves the amount of each
entirely in the user’s control.
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The ﬁnal point requires further development
in the light of the increasing interest in the
comparison and evaluation of decision aids on
the basis of multiple criteria relating to devel-
opment, performance, accessibility and impact.
Within its essential prioritization of simplic-
ity over complexity, the functionalities pro-
vided by the Annalisa-in-Elicia software create
the possibility of building decision aids that
should perform well on most criteria of adapt-
ability and personalization. According to the
Eiring et al. coding scheme for the personaliza-
tion of decision aids,29 the basic components of
personalization are media content, user fea-
tures, user model construction and representa-
tion and adaptive system behaviour. User
features can broadly be classiﬁed into the user′s
knowledge level, interests, preferences, goals/
tasks, background, individual traits and con-
text. Adaptive system behaviours include adap-
tive navigation support, adaptive selection,
organisation and presentation of content, adap-
tive search, adaptive collaboration and person-
alized recommendations. Used in conjunction
with Elicia, any implementation of Annalisa
should provide a medium to high degree of
personalization in all these respects and hence
compare favourably with the 10 of the initial
259 decision aids that were subject to detailed
classiﬁcation in the Eiring-led study.
It is up to the developer of a decision sup-
port tool within this software to determine
what degree and type of adaptational ﬂexibility
and personalization – to individuals or groups
– is to be oﬀered in terms of attributes (such as
content, language, connectivity and presenta-
tion). It is also up to the developer to deter-
mine whether these are to be provided on an
opt-in or opt-out basis. While compared with
some ideal decision aid there are limitations in
all these respects, a tool built in the Annalisa
software is capable of technically matching, or
possibly surpassing, any of the actual decision
aids subjected to intensive analysis in the
Eiring-led project. Most diﬀerences that arise
will not be for reasons of functionality, but be
traceable to their MCDA basis, because this is
what inﬂuences what is oﬀered and required –
and how it is oﬀered and required – by way of
adaptation and personalization.
This point is worth emphasizing because it is
important that a particular decision aid is
assessed as an implementation of the underly-
ing technique and philosophy within which it is
built. A tool using Annalisa is based on the
paradigm of analysis-based prescription, as
opposed to that of expertise-based description
within which all the other aids examined by
Eiring et al. have been constructed. What is
paramount in the development and use of a
particular decision support tool or system is to
make the potential user very clear about its
underlying paradigm, so that questions con-
cerning lower levels of functionality are rele-
vant to it. The appropriate evaluation of
Annalisa-based aids is therefore in comparison
with other MCDA-based ones and such a com-
parison, involving Annalisa and AHP (using
Expert Choice), carried out within Hi-View, is
that has been undertaken by Pozo-Martin (per-
sonal communication).
This makes the 2005 French and Xu30 survey
of the ﬁve MCDA packages cited earlier – Hi-
View, V.I.S.A, Web-Hipre, Expert Choice and
Logical Decisions – the most relevant available
published comparison at a functional level. A
survey of current decision analysis software,
including full technical and operational details,
is provided biennially by INFORMS. The
2012 survey results are available at http://www.
orms-today.org/surveys/das/das.html. Fifteen
packages oﬀer some form of multicriteria DA,
but this is a purely descriptive listing of informa-
tion provided by 24 vendors, with no comments
or assessments added. Of the ﬁve MCDA pack-
ages in the French and Xu comparison, V.I.S.A.
does not appear.
French and Xu compared the ﬁve programs
in terms of the aspects in which they diﬀered,
notably (using Annalisa terminology) decision
structuring, weighting elicitation, rating elicita-
tion, data presentation and sensitivity analysis.
When Annalisa, in conjunction with Elicia,
is added to the comparison, two things stand
out. First, the package fails to provide the vast
majority of the functionalities and features that
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these ﬁve oﬀer, considerably augmented in the
8 years since the survey. These functionalities
and features are entirely appropriate where
complex analysis is of beneﬁt, such as in major
projects with numerous stakeholders involved
and large amounts of resources used, but even
in such contexts the limited use of these pack-
ages either in practice or as the basis of deci-
sion support templates is noteworthy. And
even where used, the complexity of the analysis
is rarely matched in, or warranted by, the
extensive deliberation that follows, as exempli-
ﬁed in a Swedish exercise in participatory
democracy.31 Somewhat paradoxically it is the
failure of Annalisa to provide alternative and/
or more sophisticated and complex methods
for key tasks (including determining the criteria
and eliciting weights) that we regard as its
positive virtue, because it will provide the
potential for much wider use. The growth of
product comparison websites and recommender
systems within e-commerce32–35 is a clear sign
that multicriteria analysis is eminently accessi-
ble to large sections of the population, but only
at an appropriate level of complexity. William
Buxton has pointed out that the speed of tech-
nological progress captured in Moore’s Law (a
technology generation is 18 months and
decreasing) is in complete contrast to his
‘God’s law’, which states that ‘the capacity of
human beings is limited and does not increase
over time – our neurons do not ﬁre any faster,
our memory doesn’t increase in capacity, and
we do not learn or think faster as time pro-
gresses’.36 The problem this creates for the
evaluation of innovative and disruptive systems
of all kinds is succinctly captured in Martin
Buxton’s law ‘It is always too early [for rigor-
ous evaluation], until suddenly it’s too late’.37
The second diﬀerence is closely associated
with the pace of change in both the hardware
and connectivity within which any MCDA soft-
ware will operate. Both French and Xu and an
earlier study by Belton and Hodgkin in 199938
saw three main settings for use of an MCDA
package: Do-It-Yourself use by a single individ-
ual, an analyst-facilitated group meeting, and
‘oﬀ-line’ analysis by a consultant sandwiched
between face-to-face meetings with decision
makers. Subsequent developments in communi-
cation technology and connectivity means that
there are now many more possibilities, includ-
ing one in which a pre-structured (options, cri-
teria) and evidence-populated MCDA-based
decision aid is made available online. Decision
makers then need only to have their preferences
(utilities, importance weights) elicited to obtain
an opinion on the merits of the alternative
options. In terms of data presentation and dis-
play, as well as interactivity, Annalisa beneﬁts
from being developed speciﬁcally for online use
within the latest technology. Now written in
html5, with tablet use prominently in mind, it
has mobile presence on touch-operated devices
using iOS, Android and other operating sys-
tems. Such interactive mobile accessibility is
likely to trump most other functional consider-
ations in the coming years, making a level of
complexity compatible with such operation a
paramount consideration.
Annalisa was designed to embody the fol-
lowing practical principles:
1. It should be possible to undertake an analy-
sis within a very short time, such as the 5–
10 min often available in time/resource pres-
sured situations, to ensure that the possible
beneﬁts of even a modicum of ‘slow think-
ing’ should not be lost.39 This was in no
way, of course, intended to prevent weeks
or months being devoted to generating the
detailed structure and inputs – if the time
and other resources are available.
2. Irrespective of the time available at the point
of decision (and therefore including 5–
10 min), the decision owner should not be
asked to make the necessary trade-oﬀs
among more than 7  2 criteria.40,41 (Annal-
isa actually has a maximum of 10.)
3. All the elements of the decision (preferences
and evidence) and the outcome (best option)
should be simultaneously visible on the
screen, providing a complete picture of all
elements of the decision and with the eﬀects
of changing any weighting or rating dynam-
ically visible in real time.
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4. Pop-ups on the screen should provide access
to additional information, especially the
provenance of the option performance rat-
ings (including external links where appro-
priate).
Giving higher weight to practical consider-
ations, Annalisa adopts the simplest and most
colloquially familiar form of MCDA. In the
decision matrix ‘weighted-sum’ approach, all
attributes exist at the same level (there is no
hierarchy of criteria and sub-criteria); the per-
formance of each option is directly rated on
each attribute; the importance of each attribute
is directly weighted in relation to that of all the
other attributes; and the option Scores are cal-
culated by summing an option’s ratings on the
attributes multiplied by the attribute weigh-
tings.
An illustrative example of a completed An-
nalisa screen is provided in Figures 1 and 2.
These might be seen as either those for two
diﬀerent patients or those of the same patient
at two points of time (where Fig. 1 is pro-
duced at Time 0 and Fig. 2 is produced at the
next encounter i.e. Time 1). In the ratings
panel of both instances, we can see that new
treatment is better at maximizing the main
eﬀect beneﬁt than current treatment (0.70 vs.
0.50), is better at minimizing the treatment
burden than the current treatment (0.80 vs.
0.70), but is worse at minimizing side eﬀects
(0.20 vs. 0.50). (Longer bars mean the particu-
lar option does better.) The two are equally
good in relation to minimizing adverse events
(both 0.90).
Given the relative weightings of the four
attributes in Fig. 1, new treatment emerges
with the highest score in a simple expected
value calculation.
Score for CURRENT treatment
¼ ð0:50 0:50Þ þ ð0:50 0:30Þ
þ ð0:90 0:10Þ þ ð0:70 0:10Þ
¼ 0:56
Figure 1 Example of Annalisa for hypothetical Patient 1 at Time 0.
Figure 2 Example of Annalisa for hypothetical Patient 1 at Time 1.
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Score for NEW treatment
¼ ð0:70 0:50Þ þ ð0:20 0:30Þ
þ ð0:90 0:10Þ þ ð0:80 0:10Þ
¼ 0:58
Figure 2 presents the scores when the
weight assigned to minimizing side eﬀects
harm is increased, with correspondingly
reduced weight to maximizing main eﬀect ben-
eﬁt. (The weightings for the set of attributes
must sum to 1). Current treatment now has
the highest score, which means we interpret
this option as the opinion emerging from the
Annalisa.
From wherever and however they are
derived, both the ratings and the weightings
entered into Annalisa are treated as measures
on a ratio scale running from a (true) zero to 1
or 100%. Zero on the ratings scale means
either zero probability (literally, and in many
case logically, no chance) or zero fulﬁlment of
the attribute concerned; 1 means 100% proba-
bility or complete fulﬁlment. Similarly, zero on
the weightings scale means of no importance
whatsoever, and 1 means all important to the
exclusion of all other attributes.
The choice of the simple weighted-sum
approach, among many other decisions in the
design and development of the Annalisa tem-
plate, was made in the light of our value judg-
ments as to the weight to be assigned to
particular considerations. Pre-eminently, we
have assigned high weights to relevant practical
considerations in both development and deliv-
ery, in full recognition and awareness that
these may lead to poorer ratings on other crite-
ria, pre-eminently ones concerned with norma-
tive rigour. We do not see rigour/relevance and
practicality/normativity as dichotomies, where
one must make binary choices, but as matters
of weighting and hence preference sensitive.
Annalisa, as with any implementation of
MCDM including MCDD, embodies a particu-
lar view as to the criteria and weights to be
used in ‘deciding how to decide’. This point
continues to apply even when choosing among
the candidates within the ﬁeld of MCDA.
Deciding how to decide: the decision
decision
Given that a patient faces multiple options and
regards multiple criteria as relevant to choosing
among them, should they stick with MCDD,
the currently dominant decision technology, or
move to MCDA, at least as a decision support
technology?
As discussed earlier, the two basic forms of
MCDM and their many internal variations dif-
fer in important ways, as well as having key
similarities. But from the clinical decision-mak-
ing standpoint, we should not be thinking of
making a choice between them at some general
and abstract level. It hardly makes any sense
to ask whether MCDD or MCDA is better in
general as a technique. Neither is it particularly
useful to ask whether AHP/Expert Choice or
weighted-sum/Annalisa is a ‘better’ template
implementation of MCDA. We need rather to
focus on particular instantiations of each tech-
nique template in a tool for a particular clinical
decision setting, where ‘setting’ embraces such
things as the organization, the professional, the
patient and the condition involved.
This implies we need to establish the deci-
sional criteria relevant to a setting. These crite-
ria will probably include such higher-level
considerations as evidential strength and cover-
age, theoretical grounding, explicitness, preci-
sion, transparency, communicability and
potential for social or institutional biasing. But
given that this is clinical decision support, they
should also include the basic resource require-
ments, such as the time and cognitive eﬀort
and commitment required from all parties, as
well as any ﬁnancial implications for them.
It can be taken for granted that the perfor-
mance of particular implementations of MCDD
and MCDA will vary on these criteria, not least
because of conscious value judgement-based
trade-oﬀs regarding the selection and weighting
of the criteria made by individual parties in the
case of MCDD and by the developers and
implementers in the case of MCDA-based deci-
sion support. For example, an MCDA-based
aid – or MCDD-based appointment – designed
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to take no more than 20 min will (should) per-
form less well on a criterion such as ‘coverage of
the evidence’ than one assumed to have 40 min
at its disposal. The various interactive decision
support systems we are developing all allow cus-
tomization of the support process to the time
and other resources available, as well as person-
alization of the weightings by, and ratings for,
the speciﬁc patient on the selected criteria. They
explicitly assume, indeed emphasize, that such
customization choices will impact on which
aspects of the decision support will be accessed
and that the personalization of weightings will
aﬀect the outcome (opinion) emerging from the
analysis.
Thus, given that the decision on what deci-
sion procedure or decision support system to
adopt involves multiple criteria and is therefore
preference sensitive, it does not make sense to
ask whether Annalisa has, or ever can be,
shown to work in some overall or average
sense as the basis of a clinical decision support
system. The answer will vary as a function of
the particular decision maker’s preferences in
the particular context as well as the quality of
the instantiation. Empirically, we can note that
in a study with a small number of Australian
GPs, 80% agreed that the demonstrated An-
nalisa-based tool for prostate cancer screening
would be useful in discussions with their
patients and half thought it would be useful
and could be recommended for use in decisions
on any health matter.42 Pozo-Martin has
recently established the preference sensitivity of
decision support evaluation in a comparison of
Annalisa and the Analytic Hierarchy Process
for developing and delivering decision support
for patients with advanced lung cancer in some
Spanish hospitals.43 Finally, while it is not
appropriate to report the full set of results of a
RCT involving Annalisa-based decision aids
for PSA testing here, Table 1 provides
Table 1 Age of participants and individual ratings on criteria relating to usability of Annalisa decision aids for PSA testing
All, n = 1447
Annalisa for PSA
Testing with a Fixed
Set of Attributes
Chosen by
Researchers,
n = 727 (50.2%)
Annalisa for PSA
Testing with
Attributes Chosen
by Study
Participants,
n = 720 (49.8%)
n % n % n %
Age
40–49 years 591 40.8 282 38.8 309 42.9
50–59 years 487 33.7 248 34.1 239 33.2
60–69 years 369 25.5 197 27.1 172 23.9
Difficulty deciding on the Weights for Criteria
Very difficult 93 6.4 52 7.2 41 5.7
Fairly difficult 282 19.5 140 19.3 142 19.7
Neither difficult nor easy 466 32.2 235 32.3 231 32.1
Fairly easy 433 29.9 209 28.8 224 31.1
Very easy 173 12.0 91 12.5 82 11.4
Difficulty entering the Weights for Criteria
Very difficult 100 6.9 55 7.6 45 6.3
Fairly difficult 323 22.3 159 21.9 164 22.8
Neither difficult nor easy 467 32.3 242 33.3 225 31.3
Fairly easy 392 27.1 184 25.3 208 28.9
Very easy 165 11.4 87 12.0 78 10.8
Contents of Evidence panel met needs for information
Very well 362 25.0 163 22.4 199 27.6
Well 847 58.5 433 59.6 414 57.5
Not very well 238 16.5 131 18.0 107 14.9
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information on the age of participants and
their ratings on various criteria, such as diﬃ-
culty in responding to the key items on criteria
weighting, that conﬁrm its accessibility.
Given the resource requirements of decision
making and decision supporting – and hence
their opportunity costs – we suggest there is a
strong case for ‘deciding how to decide’ being
approached analytically as an exercise in ‘deci-
sion resource–decision eﬀectiveness analysis’.
This simply parallels in relation to the decision
decision (should we adopt this or that way of
deciding whether, for example, to adopt this
new drug or device technology?) the use of
conventional cost-eﬀectiveness analysis in rela-
tion to the adoption decision (should we, for
example, adopt this new drug or device tech-
nology or not?). As implied above, both
numerator and denominator in decision
resource-decision eﬀectiveness analysis are
appropriately conceptualized as multicriterial
indexes. It follows that MCDA is the appropri-
ate analytical technique for decision resource-
decision eﬀectiveness analysis.
Conclusion
A template designed to facilitate generic online
multicriteria decision support in person-centred
health care is presented in this paper as a valid
addition to the portfolio of decision support
systems available to clinicians and their
patients.
It is essential that any comparative evalua-
tion of decision support systems makes the the-
oretical basis of each aid and process very
clear to all respondents and decision stakehold-
ers. In the context of person-centred care, this
comparison will involve multiple criteria, of
which the paradigmatic basis of the aid or pro-
cess is a crucial one. The choice will be prefer-
ence sensitive, with the weighting sometimes
leading to an instantiation of multicriteria deci-
sion deliberation emerging as the best way of
deciding and at other times to an implementa-
tion of multicriteria decision analysis. Ulti-
mately whether Annalisa and similar templates
have a role to play in person-centred care is
not a question with a binary answer. The
empirical question, which will need to be itera-
tively asked and re-asked as technology and
attitudes change, concerns the precise roles it
can play in the increasingly complex world of
translational health. This is what we are
researching.
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